Chicago, IL, United States of America

Janine D North

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Janine D North: Innovator in Women's Health

Introduction

Janine D North is a prominent inventor based in Chicago, IL, known for her contributions to women's health. With a total of 4 patents, she has made significant strides in developing methods to address critical health issues.

Latest Patents

One of her latest patents focuses on methods of treating heavy menstrual bleeding. This invention relates to administering an effective amount of 4-((R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens. This innovative approach aims to provide relief for individuals suffering from heavy menstrual bleeding, whether or not they have uterine fibroids.

Career Highlights

Janine D North is currently associated with AbbVie Inc., a leading biopharmaceutical company. Her work at AbbVie has allowed her to focus on developing effective treatments that improve the quality of life for women facing health challenges.

Collaborations

Throughout her career, Janine has collaborated with notable colleagues, including Kristof Chwalisz and Laura A Williams. These partnerships have fostered an environment of innovation and have contributed to the advancement of her research and inventions.

Conclusion

Janine D North's work exemplifies the impact of innovation in women's health. Her patents and collaborations highlight her commitment to improving treatment options for heavy menstrual bleeding, making her a significant figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…